The Lynx Group
Interview with the Innovators

Real-World Management of Thyroid Cancer with TRK Inhibitors

Videos

Featuring:

Ezra Cohen, MD, FRCPSC, FASCO
Professor of Medicine
Chief
Division of Hematology/Oncology
UC San Diego
La Jolla, CA
Mary Jo Fidler, MD
Associate Professor and Section Chief
Medical Oncology
Rush University Medical Center
Chicago, IL
Dr Ezra Cohen of UC San Diego, La Jolla, CA, and Dr Mary Fidler of Rush University Medical Center, Chicago, IL, recount their clinical experiences and the journeys of patients treated with TRK inhibitors for thyroid cancer.

Related Articles

Subscribe to
Value-Based Cancer Care

Stay up to date with personalized medicine by subscribing to receive the free VBCC print publication or weekly e‑Newsletter.

I'd like to receive: